The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
The Promise of Nanotechnology in Personalized Medicine
Open accessAbstract
Both personalized medicine and nanomedicine are new to medical practice. Nanomedicine is an application of the advances of nanotechnology in medicine and is being integrated into diagnostic and therapeutic tools to manage an array of medical conditions. On the other hand, personalized medicine, which is also referred to as precision medicine, is a novel concept that aims to individualize/customize therapeutic management based on the personal attributes of the patient to overcome blanket treatment that is only efficient in a subset of patients, leaving others with either ineffective treatment or treatment that results in significant toxicity. Novel nanomedicines have been employed in the treatment of several diseases, which can be adapted to each patient-specific case according to their genetic profiles. In this review, we discuss both areas and the intersection between the two emerging scientific domains. The review focuses on the current situation in personalized medicine, the advantages that can be offered by nanomedicine to personalized medicine, and the application of nanoconstructs in the diagnosis of genetic variability that can identify the right drug for the right patient. Finally, we touch upon the challenges in both fields towards the translation of nano-personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–206 of 206
Pisarevsky, E., Blau, R., Epshtein, Y., Ben‐Shushan, D., Eldar‐Boock, A., Tiram, G., Koshrovski‐Michael, S., Scomparin, A., Pozzi, S., Krivitsky, A., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000028 · Cited by 17
Nanomedicine Beyond Tumor Passive Targeting: What Next?
Longo, J. P. F., & Muehlmann, L. A. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0208 · Cited by 16
Tao, J., Zhao, P., Zheng, J., Wu, C. S., Shi, M., Li, J., Li, Y., & Yang, R. (2015) · Chemical Communications · doi:10.1039/c5cc05520b · Cited by 15
Nanotechnology approaches for delivery of cytochrome P450 substrates in HIV treatment
Gong, Y., Chowdhury, P., Nagesh, P. K. B., Cory, T. J., Dezfuli, C., Kodidela, S., Singh, A., Yallapu, M. M., & Kumar, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1646725 · Cited by 10
Conte, C., Poggetto, G. D., Cola, V. S. D., Russo, A., Ungaro, F., Russo, G., Laurienzo, P., & Quaglia, F. (2021) · Biomaterials Science · doi:10.1039/d1bm00909e · Cited by 8
Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes
Wu, D., Vogus, D. R., Krishnan, V., Broto, M., Pusuluri, A., Zhao, Z., Kapate, N., & Mitragotri, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010107 · Cited by 6
Cited by
The Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
Clinical translation of nanomedicines for brain diseases: Current challenges and future directions
Wang, G., Wang, N., Xia, X., Ismail, M., & Shi, B. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114426 · Cited by 33
Metadata
- Authors
- Alghamdi, M. A., Fallica, A. N., Virzì, N., Kesharwani, P., Pittalà, V., & Greish, K.
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2022-04-22
- Volume
- 12
- Issue
- 5
- Pages
- 673
- ISSN
- 2075-4426 (ISSN-L)
- OpenAlex
- W4224314779
- Cited by
- 284
- References
- 206
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.